文献速递关节外科

糖尿病患者全膝关节置换术后患者报告结局改善更差吗?

Do Patients With Diabetes Have Poorer Improvements in Patient-Reported Outcomes After Total Knee Arthroplasty?
PubMed 文献 · J Arthroplasty · 2021-03-04

本研究回顾性分析2008至2018年2840例初次单侧全膝关节置换术患者的前瞻性数据,其中716例(25.2%)患有糖尿病,且仅糖化血红蛋白(HbA1c)<8.0%的血糖控制良好者方可手术。结论认为血糖控制良好的糖尿病患者在总体健康和骨关节炎结局方面可获得与非糖尿病患者相似的改善,膝关节特异性结局的轻微差异不太可能具有临床意义。

要点

  • 血糖控制良好(HbA1c<8.0%)的糖尿病患者全膝关节置换术后总体健康与骨关节炎结局改善与非糖尿病患者相似。
  • 上述膝关节特异性结局的轻微差异不太可能具有临床意义。

核心结论

  • 血糖控制良好(HbA1c<8.0%)的糖尿病患者全膝关节置换术后在总体健康和骨关节炎结局(SF-36躯体成分摘要、心理成分摘要、WOMAC、KSS-功能)方面可获得与非糖尿病患者相似的改善。
  • 糖尿病患者在膝关节特异性结局(KSS-膝关节评分和膝关节活动度)的改善上略差,但这些差异不太可能具有临床意义。

研究设计与样本

  • 回顾性分析2008至2018年前瞻性收集的2840例初次单侧全膝关节置换术患者数据,其中716例(25.2%)患有糖尿病。
  • 所有患者术前1个月内测量HbA1c,仅允许血糖控制良好(HbA1c<8.0%)的糖尿病患者接受手术。
  • 记录患者人口学特征和合并症,采用多元回归评估糖尿病对患者报告结局指标(SF-36、WOMAC、KSS)和膝关节活动度改善的影响。

关键数值与推荐

  • 仅血糖控制良好(HbA1c<8.0%)的糖尿病患者被允许接受全膝关节置换术。

临床怎么用

  • 对于血糖控制良好(HbA1c<8.0%)的糖尿病患者,全膝关节置换术后总体健康和骨关节炎结局的改善预期与非糖尿病患者相似。
  • 应告知糖尿病患者膝关节特异性结局(KSS-膝关节评分和膝关节活动度)的改善可能略差,但差异不太可能具有临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetes is one of the most common comorbidities in patients undergoing total knee arthroplasty (TKA) for osteoarthritis. However, the evidence remains unclear on how it affects patient-reported outcome measures after TKA. METHODS: We reviewed prospectively collected data of 2840 patients who underwent primary unilateral TKA between 2008 and 2018, of which 716 (25.2%) had diabetes. All patients had their HbA1c measured within 1 month before surgery, and only well-controlled diabetics (HbA1c <8.0%) were allowed to proceed with surgery. Patient demographics and comorbidities were recorded, and multiple regression was performed to evaluate the impact of diabetes on improvements in patient-reported outcome measures (Short Form 36 (SF-36), Western Ontario and McMaster University Osteoarthritis Index (WOMAC), Knee Society Score (KSS)) and knee range of motion (ROM). RESULTS: Compared with nondiabetics, patients with diabetes were more likely to possess a higher body mass index (P-value <.001), more comorbidities (P-value <.001), and poorer preoperative SF-36 Physical Component Summary (PCS) (P-value <.001), WOMAC (P-value = .002), KSS-function (P-value <.001), and knee ROM (P-value <.001). Multiple regression showed that diabetic patients experienced marginally poorer improvements in KSS-knee (-1.22 points, P-value = .025) and knee ROM (-1.67°, P-value = .013) than nondiabetics. However, there were no significant differences in improvements for SF-36 PCS (P-value = .163), Mental Component Summary (P-value = .954), WOMAC (P-value = .815), and KSS-function (P-value = .866). CONCLUSION: Patients with well-controlled diabetes (HbA1c <8.0%) can expect similar improvements in general health and osteoarthritis outcomes (SF-36 PCS and Mental Component Summary, WOMAC, and KSS-function) compared with nondiabetics after TKA. Despite having marginally poorer improvements in knee-specific outcomes (KSS-knee and knee ROM), these differences are unlikely to be clinically significant.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Zhang S, Chong M, Lau BPH, et al. Do Patients With Diabetes Have Poorer Improvements in Patient-Reported Outcomes After Total Knee Arthroplasty? J Arthroplasty. 2021. PMID: 33775468. doi:10.1016/j.arth.2021.02.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。